skip nav
National Prevention Information Network
Search Help
Other Searches: Search Organizations | Search Materials | Search Campaign Resources | Search Funding
español
Share Share this page on Twitter Share this page on Facebook Share this page on LinkedIn View more options to share this page E-mail this page to a colleague Print this page


<< Back

News

Boehringer’s HIV Drug Has Edge over BMS’ Reyataz

Abstract
A study of 569 patients indicates that Boehringer Ingelheim’s drug Viramune suppressed HIV as well as Bristol Myers Squibb’s drug Reyataz but had a more favorable effect on cardiovascular risks. The results were presented over the weekend at the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Cape Town, South Africa. To amplify their effects, both drugs were taken with Gilead Sciences’ combination treatment Truvada. Reyataz was also combined with Norvir, made by Abbott Laboratories. Study patients treated with Viramune had more than twice the level of HDL, or “good cholesterol,” as those treated with Reyataz, Boehringer said. The company added that the ratio of total cholesterol over HDL cholesterol, a measure that indicates elevated cardiovascular risks, was more favorable in the patients treated with Viramune. The European Commission has already approved an update of Viramune’s product description to note its effect on blood lipids, Boehringer said.
Source
http://www.reuters.com
Date of Publication
07/20/2009
Author
Ludwig Burger
Article Type
General media
Article Category
Medical News
Subjects
Adverse Reactions
Antiretroviral Drugs
HIV/AIDS Treatment or Therapies
Studies or Surveys
Therapeutic Drugs

Disclaimer: NPIN provides this information as a public service only. The views and information provided about the materials, funding opportunities, and organizations do not necessarily state or reflect those of the U.S. Department of Health and Human Services, CDC, or NPIN.

cdcnpin.org News Record #53603

<< Back

CDCNPIN.org

Contact Us
About Us
HIV Content Notice
Privacy Policy
Policies & Disclaimers
Site Index
Help Using the CDC NPIN Web Site

CDC NPIN Searches

Search Organizations
Search Materials
Search Funding Opportunities
Search Campaign Resources
Help Using the CDC NPIN Searches

CDC NPIN Resources

hivtest.cdc.gov
m.hivtest.cdc.gov
findtbresources.org
STD Awareness Microsite
findstdtest.org
AIDS Gov Logo and Link CDC Logo and Link